Avadel's Tshuag poob 21% tom qab tshaj tawm FDA thov tshiab rau kev sim tshuaj narcolepsy

Shares ntawm Avadel Pharmaceuticals PLC
AVDL,
+ 133.64%

poob 21.6% hauv kev ua lag luam ua ntej hnub Thursday tom qab lub tuam txhab tau hais hauv daim ntawv pov thawj tias Lub Chaw Tswj Xyuas Khoom Noj thiab Tshuaj tau thov cov ntaub ntawv ntxiv rau nws qhov kev sim tshuaj narcolepsy. Avadel tau hais tias tam sim no nws cia siab tias yuav tau txais FDA txiav txim siab ntawm cov tshuaj, FT218, los ntawm Lub Rau Hli xyoo tom ntej. Lub tuam txhab cov khoom lag luam poob qis 58.1% xyoo no, thaum S&P 500
SPX,
+ 2.47%

tau poob 16.5%.

Source: https://www.marketwatch.com/story/avadels-stock-falls-21-after-disclosing-new-fda-request-for-experimental-narcolepsy-drug-2022-05-26?siteid=yhoof2&yptr=yahoo